Our studies showed that temsirolimus, an inhibitor of mTOR [14], reduced cancer cell growth slightly, but did not cause cell death against the “resistant” type of renal cell carcinomas under glucose deprivation (Figure 4D). The gene discussed is MTOR; the disease is hereditary clear cell renal cell carcinoma.